Literature DB >> 8809844

alpha-1-antichymotrypsin interaction with A beta (1-40) inhibits fibril formation but does not affect the peptide toxicity.

M V Aksenova1, M Y Aksenov, D A Butterfield, J M Carney.   

Abstract

Recent studies have shown that senile plaque-associated or glial-derived proteins can prevent fibril formation of beta-amyloid peptide (A beta), while increasing the neurotoxicity of the latter (in the case of glutamine synthetase, apolipoprotein J or thrombin). alpha-1-Antichymotrypsin (ACT) is a glial-derived protein associated with senile plaques in the Alzheimer's brain. In this report we show that ACT, a minor protein component of beta-amyloid deposits, is able to inhibit A beta (1-40) aggregation into fibrils, but unable to modulate the toxicity of A beta (1-40) in primary rat hippocampal cell cultures. These results are discussed in terms of the potential role of glial-derived proteins on A beta aggregation and neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8809844     DOI: 10.1016/0304-3940(96)12717-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Cytokine production by a human microglial cell line: effects of beta-amyloid and alpha-melanocyte-stimulating hormone.

Authors:  Catharina Lindberg; Erik Hjorth; Claes Post; Bengt Winblad; Marianne Schultzberg
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

2.  Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice.

Authors:  L Mucke; G Q Yu; L McConlogue; E M Rockenstein; C R Abraham; E Masliah
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

3.  Beta-amyloid protein structure determines the nature of cytokine release from rat microglia.

Authors:  Catharina Lindberg; Maj-Linda Bardyl Selenica; Anita Westlind-Danielsson; Marianne Schultzberg
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

4.  Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.

Authors:  D M Hartley; D M Walsh; C P Ye; T Diehl; S Vasquez; P M Vassilev; D B Teplow; D J Selkoe
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

5.  The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.

Authors:  G P Lim; T Chu; F Yang; W Beech; S A Frautschy; G M Cole
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

Review 6.  Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.

Authors:  Christopher D Aluise; Renã A Sowell; D Allan Butterfield
Journal:  Biochim Biophys Acta       Date:  2008-08-07

7.  Fine mapping of the amyloid β-protein binding site on myelin basic protein.

Authors:  Annmarie E Kotarba; Darryl Aucoin; Michael D Hoos; Steven O Smith; William E Van Nostrand
Journal:  Biochemistry       Date:  2013-04-04       Impact factor: 3.162

8.  SerpinB2 (PAI-2) Modulates Proteostasis via Binding Misfolded Proteins and Promotion of Cytoprotective Inclusion Formation.

Authors:  Jodi A Lee; Justin J Yerbury; Natalie Farrawell; Robert F Shearer; Patrick Constantinescu; Danny M Hatters; Wayne A Schroder; Andreas Suhrbier; Mark R Wilson; Darren N Saunders; Marie Ranson
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

Review 9.  Indian Medicinal Herbs and Formulations for Alzheimer's Disease, from Traditional Knowledge to Scientific Assessment.

Authors:  Jogender Mehla; Pooja Gupta; Monika Pahuja; Deepti Diwan; Diksha Diksha
Journal:  Brain Sci       Date:  2020-12-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.